Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma patients: a prospective non-randomized controlled study
<b>Objective</b> Anti-angiogenic drugs are an emerging treatment option against malignant tumors. The aim of this study was to determine whether the addition of perioperative rh-endostatin to chemotherapy could improve the probability of distant metastasis-free survival (DMFS) and overal...
Main Authors: | Hairong Xu, Zhen Huang, Yuan Li, Qing Zhang, Lin Hao, Xiaohui Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2019-03-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1369 |
Similar Items
-
Efficacy and Safety of rh-Endostatin Combined with Chemotherapy
versus Chemotherapy Alone for Advanced NSCLC: A Meta-analysis Review
by: Jinzhong ZHANG, et al.
Published: (2011-05-01) -
Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: Implication in tumor progression and prognosis
by: Dalia M. Abd El-Rehim, et al.
Published: (2015-03-01) -
Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis
by: Cheng-Qiong Wang, et al.
Published: (2021-08-01) -
Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature
by: Robert Serpico, et al.
Published: (2021-03-01) -
Animal study of rh-endostatin combined with ginsenoside Rg3 on inhibiting growth of breast cancer xenografts
by: Chuan-Ming Tong, et al.
Published: (2016-03-01)